FI923425A - Foerfarande foer framstaellning av immunoglobulinloesningar inaktiverade med avseende pao virus - Google Patents

Foerfarande foer framstaellning av immunoglobulinloesningar inaktiverade med avseende pao virus Download PDF

Info

Publication number
FI923425A
FI923425A FI923425A FI923425A FI923425A FI 923425 A FI923425 A FI 923425A FI 923425 A FI923425 A FI 923425A FI 923425 A FI923425 A FI 923425A FI 923425 A FI923425 A FI 923425A
Authority
FI
Finland
Prior art keywords
virus
inaktiverade
immunoglobulinloesningar
pao
foerfarande foer
Prior art date
Application number
FI923425A
Other languages
English (en)
Other versions
FI923425A0 (fi
FI107122B (fi
Inventor
Werner Gehringer
Patrick Selosse
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6437560&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI923425(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI923425A0 publication Critical patent/FI923425A0/fi
Publication of FI923425A publication Critical patent/FI923425A/fi
Application granted granted Critical
Publication of FI107122B publication Critical patent/FI107122B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI923425A 1991-08-02 1992-07-29 Menetelmä virusten suhteen inaktivoitujen immunoglobuliiniliuosten valmistamiseksi FI107122B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4125625 1991-08-02
DE4125625A DE4125625C2 (de) 1991-08-02 1991-08-02 Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen

Publications (3)

Publication Number Publication Date
FI923425A0 FI923425A0 (fi) 1992-07-29
FI923425A true FI923425A (fi) 1993-02-03
FI107122B FI107122B (fi) 2001-06-15

Family

ID=6437560

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923425A FI107122B (fi) 1991-08-02 1992-07-29 Menetelmä virusten suhteen inaktivoitujen immunoglobuliiniliuosten valmistamiseksi

Country Status (14)

Country Link
US (1) US5648472A (fi)
EP (1) EP0525502B2 (fi)
JP (1) JP2969310B2 (fi)
KR (1) KR100188448B1 (fi)
AT (1) ATE143812T1 (fi)
CZ (1) CZ291813B6 (fi)
DE (2) DE4125625C2 (fi)
DK (1) DK0525502T4 (fi)
ES (1) ES2092604T5 (fi)
FI (1) FI107122B (fi)
IL (1) IL102525A (fi)
SK (1) SK280680B6 (fi)
YU (1) YU48242B (fi)
ZA (1) ZA925764B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
CN1520885A (zh) † 1997-10-23 2004-08-18 ������ҩ��ʽ���� 可室温贮存的免疫球蛋白静脉注射制剂
DE10016877A1 (de) * 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
ES2318145T3 (es) 2002-02-19 2009-05-01 Resolution Chemicals Limited Esterilizacion de esteroides por medio de disolventes.
DK1654284T3 (da) * 2003-08-12 2009-07-20 Octapharma Ag Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
WO2005082937A2 (en) 2004-02-27 2005-09-09 Octapharma Ag A method of providing a purified, virus safe antibody preparation
FR2944281B1 (fr) * 2009-04-08 2011-07-29 Fabre Pierre Dermo Cosmetique Derives soufres de resorcinol, leur preparation et leurs utilisations cosmetiques
BR112020005229A2 (pt) * 2017-09-18 2020-09-24 Bayer Healthcare Llc métodos de inativação de vírus usando n-metilglucamida e seus derivados

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography

Also Published As

Publication number Publication date
IL102525A0 (en) 1993-01-14
EP0525502B2 (de) 2005-08-10
ES2092604T3 (es) 1996-12-01
IL102525A (en) 2005-05-17
KR930004329A (ko) 1993-03-22
JPH05202100A (ja) 1993-08-10
ES2092604T5 (es) 2006-03-01
EP0525502A1 (de) 1993-02-03
DK0525502T4 (da) 2005-09-19
JP2969310B2 (ja) 1999-11-02
DE4125625C2 (de) 1999-12-02
DK0525502T3 (da) 1997-03-17
CZ236992A3 (en) 1993-02-17
YU74092A (sh) 1995-10-24
YU48242B (sh) 1997-08-22
SK280680B6 (sk) 2000-06-12
FI923425A0 (fi) 1992-07-29
ATE143812T1 (de) 1996-10-15
SK236992A3 (en) 1995-01-05
FI107122B (fi) 2001-06-15
DE59207324D1 (de) 1996-11-14
DE4125625A1 (de) 1993-02-04
EP0525502B1 (de) 1996-10-09
KR100188448B1 (ko) 1999-06-01
US5648472A (en) 1997-07-15
ZA925764B (en) 1993-04-28
CZ291813B6 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
FI923425A (fi) Foerfarande foer framstaellning av immunoglobulinloesningar inaktiverade med avseende pao virus
DE69332310D1 (de) Verfahren zur herstellung von vorgefüllten, sterilen abgabevorrichtungen.
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
DK0432117T3 (da) Farmaceutisk præparat til behandling af inflammation
DE3479583D1 (en) High titer cytomegalovirus human immune serum globulin and method of making same
DE69413615D1 (de) Katalysator und Verfahren zur Entfernung von Stickstoffoxiden
DK422589A (da) Farmaceutisk praeparat til behandling af immundefekttilstande
BG95241A (bg) Метод за получаване на 2,9-дизаместени-4н-пиридо/1.2-а/ пиримидин-4-они
DK0391644T3 (da) Arylsubstituerede rhodaninderivater
DE69610109D1 (de) Halbleiterkomponente mit verbesserter sicherheit;halbleiterschaltkreisanordung und verfahren zur herstellung derselben
DE3852402D1 (de) Galliumnitridartige Halbleiterverbindung und daraus bestehende lichtemittierende Vorrichtung sowie Verfahren zu deren Herstellung.
DE59202300D1 (de) Epitaxierte Halbleiterscheiben mit sauerstoffarmer Zone einstellbarer Ausdehnung und Verfahren zu ihrer Herstellung.
IT1196988B (it) Policarbonati ramificati contenenti composti metilen-bis-naftalenici e procedimento per la loro preparazione
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
BR0010815A (pt) Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa
ES8304431A1 (es) "un metodo para preparar una inmunoglobulina adecuada para administracion intravenosa".
IT8621230A1 (it) Policarbonati ramificati contenenti acidi alifatici policarbossilici o loro derivati e procedimento per la loro preparazione
DE3485017D1 (de) Antikoerper und antikoerper enthaltende zubereitungen fuer die inhibition von periodontitis.
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
IT8919118A0 (it) Procedimento e impianto per la lavorazione di scorie di fusione di rottami d'alluminio, di recupero di componenti e con trattamento dei gas svolti.
IT1242318B (it) Procedimento di regolazione antibloccaggio e sistema antibloccaggio per la esecuzione del procedimento, in particolare per veicoli da altavelocita'.
PT91610A (pt) Process for the preparation of compounds for the treatment of arteritis rheumatoidal
DK0841954T3 (da) Fremgangsmåde til fremstilling af et virussikkert, terapeutisk, biologisk apparat